GAMMA Investing’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.57K Sell
1,871
-192
-9% -$362 ﹤0.01% 3776
2026
Q2
$2.68K Sell
2,063
-740
-26% -$1.02K ﹤0.01% 3677
2026
Q1
$3.62K Buy
2,803
+698
+33% +$1.15K ﹤0.01% 3490
2025
Q4
$4.65K Buy
+2,105
New +$3.96K ﹤0.01% 3312
2025
Q2
– Sell
-269
Closed -$1.81K – 3849
2025
Q1
$1.81K Buy
+269
New +$1.91K ﹤0.01% 3436

Other funds holding LUNG

GAMMA Investing's LUNG Position: Q3 2026 in Review

GAMMA Investing reduced its Pulmonx (LUNG) stake by 9.3% in Q3 2026, selling an estimated $362 and leaving 1,871 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

GAMMA Investing first reported a position in LUNG in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.65K in Q4 2025. 5 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

  • GAMMA Investing held 1,871 shares of Pulmonx worth $3.57K as of Q3 2026.
  • GAMMA Investing sold 192 Pulmonx shares in Q3 2026, an estimated $362.
  • Pulmonx made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3776 holding.
  • GAMMA Investing first reported a position in Pulmonx in Q1 2025 and has held it in 5 quarters since.
  • GAMMA Investing's Pulmonx position peaked at $4.65K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.